Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : BORL: Time to BUY! -- Ignore unavailable to you. Want to Upgrade?

To: TTOSBT who wrote (10155)	4/24/1998 5:38:00 PM
From: shane forbes	Read Replies (1) \| Respond to of 10836

"What got through": The mistake of ignroing the fact that the 37 m. was for last year not this year as the article implicitly suggested. Bet Visigenic helped BORL this q in terms of overall revenue. Hurt BORL in terms of integration charges etc. Still believe that the merger is big time beneficial long term. Just check out the new enterprise products that came out. Bet that combining R&D from the 2 companies led to this. Merely licensing the ORB would have not led to these things. We shall hope that this tighter integration leads to increased revenues (SHARPLY increased revenues) later on. Shane.